PARTNERS & ECOSYSTEM
Partnering with global MR leaders to advance drug-device commercialization
Biosotop builds a multi-nuclear MR metabolic imaging ecosystem together with device vendors, research institutes and clinical centers, accelerating the translation of stable-isotope tracers from research to clinic.
Partner Ecosystem
Equipment vendors, research platforms and clinical centers jointly drive implementation
Equipment Vendor
Equipment Vendor
Equipment Vendor
Equipment Vendor
Research Institute
Clinical Institution
Clinical Institution
Global Collaboration
Research hotspots and industry competition are forming in parallel
Overseas institutions such as Yale, the University of Minnesota, Cambridge, Stanford, Utrecht University and UCSF continue to advance deuterium metabolic imaging research; domestically, SIAT (CAS), Wuhan Tongji, Shanghai Ruijin, the SYSU Cancer Center and Peking Union Medical College Hospital are also conducting clinical and research collaborations.
Overseas research network
Domestic research platforms
Clinical institutions
Equipment-vendor synergy
Commercial Synergy
From equipment upgrades to reagent integration, forming a closed drug-device loop
Signed strategic cooperation agreements with GE and United Imaging to advance market and clinical applications.
Advancing sales cooperation with the four major equipment vendors — GE, Siemens, Philips and United Imaging.
Expanding the application ecosystem around multi-nuclear MR installations, research sales and clinical indications.